Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/detail.php on line 234

Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 82

Warning: array_push() expects parameter 1 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 85
Pharmalicensing | Life Science's Global Technology Marketplace
Save this technology
close
Save to Existing Project
Save to a New Project
Esmolol 100mg/10ml Vial
Orpha Swiss GmbH Switzerland flag Switzerland
Abstract ID:
Ultrashort acting beta blocker Esmolol for use in anesthesia, intensive care, cardiology and internal medicine....
Contact
Participants
You
Email me a copy of this message
MECHANISM OF ACTION
Beta blocker, selective blockade of beta 1 receptors

Esmolol is an ultra fast acting beta1-receptor blocker (cardio selective) with a very short elimination half-life of 9 minutes. This product is used for the short-term treatment of supraventricular tachycardia and for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short acting agent is desirable (e.g. myocardial infarct). Target groups are anaesthetists and ICU-clinicians. Generic version.

GO PREMIUM TO GET PATENT INFORMATION
Type of Business Relationship Sought

Country-specific or regional distribution contract.

FEATURED
Last Updated Sep 2013
Technology Type THERAPEUTIC
Phase of Development REGISTERED / FINISHED PRODUCT
CORPORATION
Company Logo